Sanofi's (SNY) Genzyme Reports Statistically Significant Top-Line Data from TOWER

June 1, 2012 7:14 AM EDT Send to a Friend
Genzyme, a Sanofi company (NYSE: SNY), reports top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login